Loxo-Bayer cancer drug gets priority review from FDA Ruby Khatun Khatun1 Jun 2018 9:30 AM ISTLoxo Oncology and Bayer AG said the U.S. Food and Drug Administration granted priority review to their cancer drug and would decide on the marketing...
Roche Perjeta regimen gets FDA priority review in breast cancer Ruby Khatun Khatun4 Oct 2017 9:20 AM ISTZURICH: The U.S. Food and Drug Administration (FDA) has granted a priority review for Roche's Perjeta in combination with Herceptin and chemotherapy...
